Passa al contenuto
Merck
  • AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival.

AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival.

The Journal of pathology (2014-11-20)
Mercedes Rodriguez-Teja, Julian H Gronau, Claudia Breit, Yu Zhi Zhang, Ai Minamidate, Matthew P Caley, Afshan McCarthy, Thomas R Cox, Janine T Erler, Luke Gaughan, Steven Darby, Craig Robson, Francesco Mauri, Jonathan Waxman, Justin Sturge
ABSTRACT

Biomechanical strain imposed by age-related thickening of the basal lamina and augmented tissue stiffness in the prostate gland coincides with increased cancer risk. Here we hypothesized that the structural alterations in the basal lamina associated with age can induce mechanotransduction pathways in prostate epithelial cells (PECs) to promote invasiveness and cancer progression. To demonstrate this, we developed a 3D model of PEC acini in which thickening and stiffening of basal lamina matrix was induced by advanced glycation end-product (AGE)-dependent non-enzymatic crosslinking of its major components, collagen IV and laminin. We used this model to demonstrate that antibody targeted blockade of CTLD2, the second of eight C-type lectin-like domains in Endo180 (CD280, CLEC13E, KIAA0709, MRC2, TEM9, uPARAP) that can recognize glycosylated collagens, reversed actinomyosin-based contractility [myosin-light chain-2 (MLC2) phosphorylation], loss of cell polarity, loss of cell-cell junctions, luminal infiltration and basal invasion induced by AGE-modified basal lamina matrix in PEC acini. Our in vitro results were concordant with luminal occlusion of acini in the prostate glands of adult Endo180(Δ) (Ex2-6/) (Δ) (Ex2-6) mice, with constitutively exposed CTLD2 and decreased survival of men with early (non-invasive) prostate cancer with high epithelial Endo180 expression and levels of AGE. These findings indicate that AGE-dependent modification of the basal lamina induces invasive behaviour in non-transformed PECs via a molecular mechanism linked to cancer progression. This study provides a rationale for targeting CTLD2 in Endo180 in prostate cancer and other pathologies in which increased basal lamina thickness and tissue stiffness are driving factors. © 2014 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Acetonitrile, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
Acetonitrile, HPLC Plus, ≥99.9%
Sigma-Aldrich
Acido formico, reagent grade, ≥95%
Sigma-Aldrich
Acetonitrile, ACS reagent, ≥99.5%
Sigma-Aldrich
Acido formico, ACS reagent, ≥96%
Sigma-Aldrich
Acetonitrile, anhydrous, 99.8%
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Sodium azide, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Sodio cloruro, Molecular Biology, DNase, RNase, and protease, none detected, ≥99% (titration)
Sigma-Aldrich
Acetonitrile, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
Sodio cloruro, 5 M in H2O, BioReagent, Molecular Biology, suitable for cell culture
Sigma-Aldrich
Sodio cloruro, BioXtra, ≥99.5% (AT)
Sigma-Aldrich
Cianoboroidruro di sodio, reagent grade, 95%
Sigma-Aldrich
Sodio cloruro, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99%
Sigma-Aldrich
Sodio cloruro, 0.9% in water, BioXtra, suitable for cell culture
Sigma-Aldrich
Acido formico, ACS reagent, ≥88%
Sigma-Aldrich
Sodium azide, BioUltra, ≥99.5% (T)
Supelco
Chloromethane solution, 200 μg/mL in methanol, analytical standard
Sigma-Aldrich
Sodio cloruro, 5 M
SAFC
Sodio cloruro, 5 M
Sigma-Aldrich
Cyanogen bromide, reagent grade, 97%
Sigma-Aldrich
Sodium azide, purum p.a., ≥99.0% (T)
Sigma-Aldrich
Sodio cloruro, BioUltra, Molecular Biology, ≥99.5% (AT)
Sigma-Aldrich
Sodium azide, BioXtra
Sigma-Aldrich
Sodio cloruro, meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%
Sigma-Aldrich
Sodio cloruro, BioUltra, Molecular Biology, ~5 M in H2O
Sigma-Aldrich
Sodio cloruro, 99.999% trace metals basis
Sigma-Aldrich
Aminoguanidine hydrochloride, ≥98%
Supelco
Sodio cloruro, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Glycolaldehyde dimer, crystalline, mixture of stereoisomers. Melts between 80 and 90 °C depending on stereoisomeric composition